Pharvaris N.V.
PHVS | NASDAQ
$35.19
-$0.83 (-2.30%)
Sep 22, 2026, 12:03 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 8.44K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -8.44K |
Operating Income | -169.82M | -145.69M | -96.91M | -86.71M | -54.14M | -28.51M |
Interest Income | n/a | 5.47M | n/a | 16.11 | 267.51 | 92.47 |
Pretax Income | -173.71M | -132.4M | -99.83M | -75.65M | -42.66M | -29.72M |
Net Income | -175.7M | -134.22M | -100.88M | -76.33M | -42.73M | -29.62M |
Selling & General & Admin | 45.34M | 47.12M | 31.34M | 29.34M | 18.35M | 6.26M |
Research & Development | 124.48M | 98.56M | 65.58M | 57.38M | 35.79M | 22.24M |
Other Expenses | n/a | 0 | n/a | 0 | n/a | n/a |
Operating Expenses | 169.82M | 145.69M | 96.91M | 86.71M | 54.14M | 28.5M |
Interest Expense | n/a | n/a | n/a | 16.11K | 278.18K | 92.47K |
Selling & Marketing Expenses | n/a | 400K | n/a | 300K | n/a | n/a |
Cost & Expenses | 169.82M | 145.69M | 96.91M | 86.71M | 54.14M | 28.51M |
Income Tax Expense | 1.99M | 1.83M | 1.05M | 679.09K | 70.12K | -94.9K |
Shares Outstanding (Basic) | 59.16M | 54.02M | 38.39M | 33.59M | 30.41M | 30.52M |
Shares Outstanding (Diluted) | 59.16M | 54.02M | 38.39M | 33.59M | 30.41M | 30.52M |
EPS (Basic) | -2.97 | -2.48 | -2.63 | -2.27 | -1.41 | -0.85 |
EPS (Diluted) | -2.97 | -2.48 | -2.63 | -2.27 | -1.41 | -0.85 |
EBITDA | -173.29M | -145.59M | -99.57M | -86.56M | -42.31M | -29.71M |
EBIT | -173.71M | -145.69M | -99.83M | -86.71M | -42.38M | -29.72M |
Depreciation & Amortization | 418.35K | 95K | 257.55K | 152.94K | 77.37K | 8.44K |
Add to Watchlist
Select watchlists to add or remove PHVS